Agilent Technologies Inc (NYSE:A)

69.31
BATS BZX Real-Time Price
As of 2:09pm ET
 -2.31 / -3.23%
Today’s Change
61.13
Today|||52-Week Range
90.64
-18.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$22.0B

Company Description

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Contact Information

Agilent Technologies, Inc.
5301 Stevens Creek Boulevard
Santa Clara California 95051
P:(800) 227-9770
Investor Relations:
(408) 345-8948

Employees

Shareholders

Mutual fund holders47.43%
Other institutional40.70%
Individual stakeholders1.40%

Top Executives

There are no executives to display.